Don’t miss the latest developments in business and finance.

Marksans Pharma gets final approval for Dutasteride Soft Gelatin Capsules

Image
Capital Market
Last Updated : Apr 11 2017 | 12:01 AM IST

From USFDA

Marksans Pharma announced that on 07 April 2017, the USFDA has granted final approval of the Abbreviated New Drug Application for Dutasteride Soft Gelatin Capsules 0.5 mg, which is therapeutically equivalent to the reference listed drug (RLD), Avodart Capsules, 0.5 mg of GlaxoSmithKline.

Durasteride is indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate. Marksans will launch the product immediately.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Apr 10 2017 | 12:48 PM IST

Next Story